Surgical And Clinical Outcomes With Neoadjuvant Atezolizumab In Resectable Stage Ib-Iiib Nsclc: Lcmc3 Trial Primary Analysis
J. Lee,J. Chaft,A. Nicholas,A. Patterson,S. Waqar,E. Toloza,E. Haura,D. Raz,K. Reckamp,R. Merritt,D. Owen,D. Finley,C. Mcnamee,J. Blasberg,E. Garon,J. Mitchell,R. Doebele,F. Baciewicz,M. Nagasaka,H. Pass,K. Schulze,S. Phan,A. Johnson,P. Bunn,B. Johnson,M. Kris,D. Kwiatkowski,I. Wistuba,D. Carbone,V. Rusch JOURNAL OF THORACIC ONCOLOGY(2021)
关键词
Neoadjuvant, atezolizumab, Early Stage Lung Cancer
AI 理解论文
溯源树
样例